Global Vaccines Markets

Table of Contents

• 1. Executive Summary
  • 1. Executive Summary
    • 1. Executive Summary
• 2. Total Vaccines Markets
  • 1. Market Overview
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Market Segmentation
    • 4. Research Methodology
  • 2. SWOT Analysis and Revenue Forecasts
    • 1. SWOT Analysis
    • 2. Revenue Forecasts
  • 3. Market Challenges and Strategies
    • 1. Market Challenges
    • 2. Strategic Recommendations
  • 4. Frost and Sullivan Awards
    • 1. Growth Strategy Leadership of the Year Award
    • 2. Product Innovation of the Year Award
• 3. North American Vaccines Markets
  • 1. Market Overview
    • 1. Introduction
    • 2. Market Engineering Measurements
  • 2. Market Drivers Restraints and Trends
    • 1. Market Drivers
      • a. Positive Economic Impact of Vaccination Encourages Immunization Programs
      • b. Wider Media Coverage on Emerging Diseases and Increased Threat of Outbreaks Drives Vaccination Programs
      • c. Combination Vaccines Reduce Number of Physician Visits and Risk of Missed Shots and Encourages Vaccination
      • d. Launch of New Rotavirus and HPV Vaccines likely to Drive Growth of Market
      • e. Novel Delivery Platforms and Technologies Encourage Usage of Vaccines
    • 2. Market Restraints
      • a. High Barriers to Entry of New Vaccine Manufacturers Restrains Growth
      • b. High Cost of Clinical Trials for Already Existing Vaccines Discourages Introduction in U.S
      • c. Anti-Vaccination and Misinformation Groups Create Negative Image for Vaccines
      • d. Imbalance Between Vaccine Manufacturing Costs and Selling Prices Creates Fragility in Vaccine Supply
      • e. Success of Immunization Programs Creates Problems for Physicians and Patients
    • 3. Market Trends
  • 3. Revenue Forecast and Competitive Structure
    • 1. Revenue Forecasts
    • 2. Competitive Structure
• 4. European Vaccines Markets
  • 1. Market Overview
    • 1. Introduction
    • 2. Market Engineering Measurements
  • 2. Market Drivers Restraints and Trends
    • 1. Market Drivers
      • a. Strong Local Presence of Leading Vaccine Manufacturers Drives Growth
      • b. Huge Unmet Medical Need in Non-Pediatric Segment Presents Opportunity for Market Expansion
      • c. Launch of Human Papilomavirus Virus and Rotavirus Vaccine Drives Market Expansion
      • d. Expanded Use of Prevnar and Launch of Streptorix Propels Usage and Drives Expansion
      • e. Threat of Flu Pandemic drives Demand for Flu Vaccines
    • 2. Market Restraints
      • a. Highly Fragmented and Heterogeneous Local Markets Creates Barriers for Vaccine Manufacturers
      • b. Price Caps on Vaccines Lowers Margins for Manufacturers
      • c. Increasing Cost of Manufacturing and Clinical Trials Restrains Expansion Activities
    • 3. Market Trends
  • 3. Revenue Forecast and Competitive Structure
    • 1. Revenue Forecasts
    • 2. Competitive Structure
• 5. Rest-of-World Vaccines Markets
  • 1. Market Overview
    • 1. Introduction
    • 2. Market Engineering Measurements
  • 2. Market Drivers Restraints Trends
    • 1. Market Drivers
      • a. Huge Population Base offers Immense Growth Potential
      • b. Increasing Private-Public Partnerships Encourage Immunization Programs
      • c. Rising Economic Prowess of Developing Countries Encourages Healthcare Initiatives
      • d. High Birth Rates Ensure Consistent Demand for Pediatric Vaccines
    • 2. Market Restraints
      • a. Delivery of Vaccines in the Absence of a Structured Healthcare System is likely to Restrain Growth
      • b. Limited Public Awareness Among the Illiterate Curbs Immunization Programs
      • c. The Lack of Infrastructure to Handle Storage and Supply of Vaccines Deters Growth
      • d. Rising Manufacturing Costs Coupled with Limited Resources Creates Cost Pressures for Manufacturers
    • 3. Market Trends
  • 3. Revenue Forecast and Competitive Structure
    • 1. Revenue Forecasts
    • 2. Competitive Structure
• 6. Decision Support Databases
  • 1. Global Disease Profile
    • 1. Diphtheria Incidences
    • 2. Haemophilius Influenza B Incidences
    • 3. Hepatitis B Incidences
    • 4. Measles Incidences
    • 5. Mumps Incidences
    • 6. Rubella Incidences
    • 7. Pertussis Incidences

List of Figures

Chapter 2

• Vaccines Market: SWOT Analysis (World), 2006-2012
• Vaccines Market: Revenue Forecasts (World), 2002-2012
• Vaccines Market: Market Share Trends of Major Market Participants (World), 2002-2005
• Vaccines Market: Percent of Revenues by Geographic Region (World), 2002-2012
• Vaccines Market: Impact of Top Industry Challenges (World), 2006-2012
• Vaccines Market: Challenges and Corresponding Strategies (World), 2006-2012

Chapter 3

• Vaccines Market: Market Drivers Ranked in Order of Impact (North America), 2006-2012
• Vaccines Market: Market Restraints Ranked in Order of Impact (North America), 2006-2012
• Vaccines Market: Revenue Forecasts (North America), 2002-2012
• Vaccines Market: Competitive Structure (North America), 2005

Chapter 4

• Vaccines Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2012
• Vaccines Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2012
• Vaccines Market: Revenue Forecasts (Europe), 2002-2012
• Vaccines Market: Competitive Structure (Europe), 2005

Chapter 5

• Vaccines Market: Market Drivers Ranked in Order of Impact (Rest-of-World), 2006-2012
• Vaccines Market: Market Restraints Ranked in Order of Impact (Rest-of-World), 2006-2012
• Vaccines Market: Revenue Forecasts (Rest-of-World), 2002-2012
• Vaccines Market: Competitive Structure (Rest-of-World), 2005